Annual Total Long Term Liabilities
$64.63 M
-$29.98 M-31.69%
31 December 2023
Summary:
Adverum Biotechnologies annual total long term liabilities is currently $64.63 million, with the most recent change of -$29.98 million (-31.69%) on 31 December 2023. During the last 3 years, it has risen by +$37.28 million (+136.30%). ADVM annual total long term liabilities is now -36.78% below its all-time high of $102.22 million, reached on 31 December 2021.ADVM Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$62.60 M
-$711.00 K-1.12%
30 September 2024
Summary:
Adverum Biotechnologies quarterly total long term liabilities is currently $62.60 million, with the most recent change of -$711.00 thousand (-1.12%) on 30 September 2024. Over the past year, it has dropped by -$2.60 million (-3.98%). ADVM quarterly long term liabilities is now -50.50% below its all-time high of $126.47 million, reached on 30 June 2021.ADVM Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADVM Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.7% | -4.0% |
| 3 y3 years | +136.3% | -47.5% |
| 5 y5 years | +3916.6% | +165.7% |
ADVM Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -36.8% | +136.3% | -47.5% | at low |
| 5 y | 5 years | -36.8% | +3916.6% | -50.5% | +165.7% |
| alltime | all time | -36.8% | >+9999.0% | -50.5% | >+9999.0% |
Adverum Biotechnologies Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $62.60 M(-1.1%) |
| June 2024 | - | $63.31 M(-1.1%) |
| Mar 2024 | - | $63.99 M(-1.0%) |
| Dec 2023 | $64.63 M(-31.7%) | $64.63 M(-0.9%) |
| Sept 2023 | - | $65.20 M(-0.8%) |
| June 2023 | - | $65.76 M(-7.8%) |
| Mar 2023 | - | $71.35 M(-24.6%) |
| Dec 2022 | $94.61 M(-7.4%) | $94.61 M(-0.8%) |
| Sept 2022 | - | $95.40 M(-4.8%) |
| June 2022 | - | $100.21 M(-1.0%) |
| Mar 2022 | - | $101.20 M(-1.0%) |
| Dec 2021 | $102.22 M(+273.8%) | $102.22 M(-14.3%) |
| Sept 2021 | - | $119.25 M(-5.7%) |
| June 2021 | - | $126.47 M(+371.8%) |
| Mar 2021 | - | $26.81 M(-2.0%) |
| Dec 2020 | $27.35 M(-3.6%) | $27.35 M(+1.7%) |
| Sept 2020 | - | $26.89 M(-1.7%) |
| June 2020 | - | $27.36 M(-1.9%) |
| Mar 2020 | - | $27.88 M(-1.7%) |
| Dec 2019 | $28.36 M | $28.36 M(+20.4%) |
| Sept 2019 | - | $23.57 M(+7.1%) |
| June 2019 | - | $22.00 M(-1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $22.29 M(+1285.6%) |
| Dec 2018 | $1.61 M(-77.7%) | $1.61 M(+456.7%) |
| Sept 2018 | - | $289.00 K(-83.6%) |
| June 2018 | - | $1.76 M(-4.2%) |
| Mar 2018 | - | $1.84 M(-74.4%) |
| Dec 2017 | $7.20 M(-20.7%) | $7.20 M(-5.3%) |
| Sept 2017 | - | $7.61 M(-5.9%) |
| June 2017 | - | $8.09 M(-5.8%) |
| Mar 2017 | - | $8.58 M(-5.6%) |
| Dec 2016 | $9.09 M(+76.3%) | $9.09 M(-6.2%) |
| Sept 2016 | - | $9.69 M(+10.2%) |
| June 2016 | - | $8.79 M(+51.3%) |
| Mar 2016 | - | $5.81 M(+12.8%) |
| Dec 2015 | $5.15 M(-25.9%) | $5.15 M(+3.0%) |
| Sept 2015 | - | $5.00 M(-4.2%) |
| June 2015 | - | $5.22 M(-2.9%) |
| Mar 2015 | - | $5.38 M(-22.6%) |
| Dec 2014 | $6.95 M(+4830.5%) | $6.95 M(-1.3%) |
| Sept 2014 | - | $7.04 M(-9.2%) |
| June 2014 | - | $7.76 M(+8427.5%) |
| Mar 2014 | - | $91.00 K(-35.5%) |
| Dec 2013 | $141.00 K(-74.1%) | $141.00 K |
| Dec 2012 | $544.00 K | - |
FAQ
- What is Adverum Biotechnologies annual total long term liabilities?
- What is the all time high annual total long term liabilities for Adverum Biotechnologies?
- What is Adverum Biotechnologies annual total long term liabilities year-on-year change?
- What is Adverum Biotechnologies quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Adverum Biotechnologies?
- What is Adverum Biotechnologies quarterly long term liabilities year-on-year change?
What is Adverum Biotechnologies annual total long term liabilities?
The current annual total long term liabilities of ADVM is $64.63 M
What is the all time high annual total long term liabilities for Adverum Biotechnologies?
Adverum Biotechnologies all-time high annual total long term liabilities is $102.22 M
What is Adverum Biotechnologies annual total long term liabilities year-on-year change?
Over the past year, ADVM annual total long term liabilities has changed by -$29.98 M (-31.69%)
What is Adverum Biotechnologies quarterly total long term liabilities?
The current quarterly long term liabilities of ADVM is $62.60 M
What is the all time high quarterly long term liabilities for Adverum Biotechnologies?
Adverum Biotechnologies all-time high quarterly total long term liabilities is $126.47 M
What is Adverum Biotechnologies quarterly long term liabilities year-on-year change?
Over the past year, ADVM quarterly total long term liabilities has changed by -$2.60 M (-3.98%)